Literature DB >> 22350952

Recombinant A22(G)-B31 (R)-human insulin. A22 addition introduces conformational mobility in B chain C-terminus.

Piotr Borowicz1, Elżbieta Bednarek, Wojciech Bocian, Jerzy Sitkowski, Beata Jaworska, Jerzy Mikołajczyk, Tadeusz Głąbski, Dorota Stadnik, Weronika Surmacz, Monika Bogiel, Lech Kozerski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22350952     DOI： 10.1007/s10858-012-9612-y

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN： 0925-2738            Impact factor:   2.835


× No keyword cloud information.
  22 in total

1.  Comparison of protein solution structures refined by molecular dynamics simulation in vacuum, with a generalized Born model, and with explicit water.

Authors:  Bin Xia; Vickie Tsui; David A Case; H Jane Dyson; Peter E Wright
Journal:  J Biomol NMR       Date:  2002-04       Impact factor: 2.835

Review 2.  Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir.

Authors:  P Kurtzhals
Journal:  Int J Obes Relat Metab Disord       Date:  2004-09

3.  Characterization of the solution properties of Pichia farinosa killer toxin using PGSE NMR diffusion measurements.

Authors:  W S Price; F Tsuchiya; C Suzuki; Y Arata
Journal:  J Biomol NMR       Date:  1999-02       Impact factor: 2.835

4.  Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin.

Authors:  E Ciszak; J M Beals; B H Frank; J C Baker; N D Carter; G D Smith
Journal:  Structure       Date:  1995-06-15       Impact factor: 5.006

5.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

6.  Reversible insulin self-assembly under carbohydrate control.

Authors:  Thomas Hoeg-Jensen; Svend Havelund; Peter K Nielsen; Jan Markussen
Journal:  J Am Chem Soc       Date:  2005-05-04       Impact factor: 15.419

7.  Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Authors:  S R Mudaliar; F A Lindberg; M Joyce; P Beerdsen; P Strange; A Lin; R R Henry
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Kinetics of different processes in human insulin amyloid formation.

Authors:  Mauro Manno; Manno Mauro; Emanuela Fabiola Craparo; Alessandro Podestà; Donatella Bulone; Rita Carrotta; Vincenzo Martorana; Guido Tiana; Pier Luigi San Biagio
Journal:  J Mol Biol       Date:  2006-11-09       Impact factor: 5.469

9.  Application of the random coil index to studying protein flexibility.

Authors:  Mark V Berjanskii; David S Wishart
Journal:  J Biomol NMR       Date:  2007-11-06       Impact factor: 2.835

10.  Direct insight into insulin aggregation by 2D NMR complemented by PFGSE NMR.

Authors:  Wojciech Bocian; Jerzy Sitkowski; Anna Tarnowska; Elzbieta Bednarek; Robert Kawecki; Wiktor Koźmiński; Lech Kozerski
Journal:  Proteins       Date:  2008-05-15
View more
  1 in total

1.  Biosynthetic engineered B28(K)-B29(P) human insulin monomer structure in water and in water/acetonitrile solutions.

Authors:  Piotr Borowicz; Wojciech Bocian; Jerzy Sitkowski; Elżbieta Bednarek; Diana Mikiewicz-Syguła; Dariusz Kurzynoga; Dorota Stadnik; Weronika Surmacz-Chwedoruk; Wiktor Koźmiński; Lech Kozerski
Journal:  J Biomol NMR       Date:  2013-02-13       Impact factor: 2.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.